Metabolic and renal outcomes of empagliflozin in patients with type 2 diabetes mellitus attending Armed Forces Hospital in Saudi Arabia: Retrospective cohort study

Ali A. Alshahrani; Saad S. Al Qahtani; Abrar S. Al Qahtani; Saeed M. Mashhour; Zayed S. Alkhtani; Yahya M. Alragea

doi:10.15537/smj.2023.44.7.20230094

Article Information

vol. 44 no. 7 674-678

DOI

https://doi.org/10.15537/smj.2023.44.7.20230094

PubMed

37463703

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received May 22, 2023
Accepted June 7, 2023
Published online July 17, 2023.

Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

Ali A. Alshahrani, MD, MBBS ⇑,
Saad S. Al Qahtani, B Pharm,
Abrar S. Al Qahtani, MD, MBBS,
Saeed M. Mashhour, B Pharm,
Zayed S. Alkhtani, MD, MBBS and
Yahya M. Alragea, MD, MBBS

From the Department of Family Medicine, Armed Forces Hospital, Khamis Mushait, Kingdom of Saudi Arabia.

Address correspondence and reprint request to: Dr. Ali A. Alshahrani, consultant family medicine and diabetes, Family Medicine Department, Armed Forces Hospital, Khamis Mushait, Kingdom of Saudi Arabia. E-mail: aly.alshahrani{at}gmail.com

View Full Text